Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DF289 plus DF277 in pediatric middle ear infections
NCT01395966Phase 3Completed
- Sponsor
- Laboratorios Salvat
- Start
- Jun 2011
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3 trial of ciprofloxacin and fluocinolone in acute otitis media (AOM) (3 arms), sponsored by Laboratorios Salvat. Primary endpoint: Time to Cessation of Otorrhea at 22 days. Started Jun 2011; status: completed.
02
Drugs
ciprofloxacinfluocinolone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT01395966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395966.